ProShares UltraPro Nasdaq Biotechnology (UBIO) Rises 3.09% for Feb 15

February 15, 2018 - By Michael Collier

Feb 15 is a positive day so far for ProShares UltraPro Nasdaq Biotechnology (NASDAQ:UBIO) as the ETF is active during the day after gaining 3.09% to hit $36.39 per share. The exchange traded fund has 46.62M net assets and 6.63% volatility this month.

Over the course of the day 62,498 shares traded hands, as compared to an average volume of 165,520 over the last 30 days for ProShares UltraPro Nasdaq Biotechnology (NASDAQ:UBIO).

The ETF is -55.22% of its 52-Week High and 57.40% of its low, and is currently having ATR of 1.97. This year’s performance is -52.74% while this quarter’s performance is -13.29%.

The ETF’s YTD performance is 0%, the 1 year is 0% and the 3 year is 0%.

More notable recent ProShares UltraPro Nasdaq Biotechnology (NASDAQ:UBIO) news were published by: Marketwatch.com which released: “Proshares UltraPro NASDAQ Biotechnology” on March 07, 2016, also Marketwatch.com with their article: “ProShares UltraPro Short NASDAQ Biotechnology” published on October 01, 2016, Seekingalpha.com published: “Healthcare Biotech Sector Breakout: How High Will It Go In 2018?” on January 05, 2018. More interesting news about ProShares UltraPro Nasdaq Biotechnology (NASDAQ:UBIO) were released by: Nasdaq.com and their article: “5 Reasons Why Biotech ETFs are Soaring” published on June 22, 2017 as well as Investorplace.com‘s news article titled: “Be Careful Before Loving Leveraged Biotech ETFs” with publication date: October 06, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.